Intuitive announces FDA clearance of fifth-gen da Vinci 5 robotic system

INTUITIVE SURGICAL INC

FDA 510(k) clearance obtained for da Vinci 5, Intuitive's next-generation multiport surgical robot.
System includes 150+ enhancements: force-sensing Force Feedback, improved 3D display, and 10,000x computing power vs. da Vinci Xi.
Force Feedback reduces force on tissue by up to 43% in preclinical trials; optional instruments cleared for most procedures.
Initial U.S. launch limited to development partners and mature robotic surgery programs before wider rollout.
Teleconference scheduled for March 18, 2024 to discuss features, benefits, and launch plans.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.